A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening.

Authors:
  • EME H Mules
    E H Mules
  • MKM M Kaback
    M M Kaback
  • JLJ S Lim-Steele
    J S Lim-Steele
  • CDC E Dowling
    C E Dowling
  • BAB R Akerman
    B R Akerman
  • MNM R Natowicz
    M R Natowicz
  • EGE E Grebner
    E E Grebner
  • RNR Navon
    R Navon
  • JWJ P Welch
    J P Welch

  • 1 October 1992
    • journal article
    • case report
Abstract
Deficiency of beta-hexosaminidase A (Hex A) activity typically results in Tay-Sachs disease. However, healthy subjects found to be deficient in Hex A activity (i.e., pseudodeficient) by means of in vitro biochemical tests have been described. We analyzed the HEXA gene of one pseudodeficient subject and identified both a C739-to-T substitution that changes Arg247----Trp on one allele and a previously identified Tay-Sachs disease mutation on the second allele. Six additional pseudodeficient subjects were found to have the C739-to-T mutation. This allele accounted for 32% (20/62) of non-Jewish enzyme-defined Tay-Sachs disease carriers but for none of 36 Jewish enzyme-defined carriers who did not have one of three known mutations common to this group. The C739-to-T allele, together with a "true" Tay-Sachs disease allele, causes Hex A pseudodeficiency. Given both the large proportion of non-Jewish carriers with this allele and that standard biochemical screening cannot differentiate between heterozygotes for the C739-to-T mutations and Tay-Sachs disease carriers, DNA testing for this mutation in at-risk couples is essential. This could prevent unnecessary or incorrect prenatal diagnoses.

This publication has 32 references indexed in Scilit: